NLM Citation ID:
99305292
Comment:
N Engl J Med 1999 Jul 8;341(2):118-20
N Engl J Med 1999 Nov 25;341(22):1701
Full Source Title:
New England Journal of Medicine
Publication Type:
Clinical Trial; Journal Article; Randomized Controlled Trial
Language:
English
Author Affiliation:
Institute of Surgery, Catholic University of Rome, Italy. gbrisin@tin.it
Authors:
Brisinda G; Maria G; Bentivoglio AR; Cassetta E; Gui D; Albanese A
Abstract:
BACKGROUND AND METHODS: Lateral internal sphincterotomy, the most common
treatment for chronic anal fissure,
may cause permanent injury to the anal sphincter, which can lead to fecal
incontinence. We compared two nonsurgical treatments that avert the risk of
fecal incontinence. We randomly assigned 50 adults with symptomatic chronic
posterior anal fissures
to receive treatment with either a total of 20 U of botulinum
toxin injected into the internal anal sphincter
on each side of the anterior midline or 0.2 percent nitroglycerin
ointment applied twice daily for six weeks. RESULTS: After two months, the
fissures were healed in 24 of the 25 patients (96 percent) in the
botulinum-toxin group and in 15 of the 25 (60 percent) in the nitroglycerin
group (P=0.005). No patient in either group had fecal incontinence. At some time
during treatment, five patients in the nitroglycerin
group had transient, moderate-to-severe headaches that were related to treatment.
None of the patients in the botulinum-toxin group reported adverse effects. Ten
patients who did not have a response to the assigned treatment - 1 in the
botulinum-toxin group and 9 in the nitroglycerin
group - crossed over to the other treatment; the fissures subsequently healed in
all 10 patients. There were no relapses during an average of about 15 months of
follow-up. CONCLUSIONS: Although treatment with either topical nitroglycerin
or botulinum toxin
is effective as an alternative to surgery for patients with chronic anal
fissure, botulinum
toxin is the more effective nonsurgical
treatment.
Additional Subjects:
Chemical Compound Name:
(Botulinum Toxin
Type A); (Ointments); 55-63-0 (Nitroglycerin)